Related Experiment Videos

[Dose-reduced antihypertensive agents--use in complex nonmedicamentous therapy of hypertension]

K D Dück1, H Holtz, J Heinrich

  • 1Poliklinik für Innere Medizin, Medizinischen Akademie Erfurt.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|January 1, 1989
PubMed

Insights

Complementary non-medicamentous therapy (CNT) for hypertension significantly reduced medication needs by nearly half. While not directly lowering blood pressure, CNT positively impacted atherogenic lipids, indicating potential cardiovascular benefits.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Pharmacology

Background:

  • Hypertension management often relies heavily on medication.
  • Non-medicamentous therapies (CNT) are increasingly explored for complementary roles.
  • Assessing the impact of CNT on medication consumption and cardiovascular risk factors is crucial.

Purpose of the Study:

  • To evaluate the influence of complementary non-medicamentous therapy (CNT) on medication use and coronary risk in hypertensive patients.
  • To compare outcomes between hypertensive patients receiving CNT alongside medication versus those on medication alone.

Main Methods:

  • A 6-month controlled study involving 73 hypertensive patients in a CNT group and a control group.
  • Monitoring blood pressure, antihypertensive drug needs, and hypertension-associated risk factors.
  • Utilizing control methods to exclude direct blood pressure reduction by CNT.

Main Results:

  • The CNT group demonstrated a medication economization of nearly 50% compared to the control group.
  • A causal, non-medicamentous blood pressure decrease was ruled out.
  • Metabolic effects of CNT led to a positive alteration in atherogenic lipids.

Conclusions:

  • Complementary non-medicamentous therapy can significantly reduce antihypertensive medication requirements.
  • CNT positively influences cardiovascular risk factors, specifically atherogenic lipids.
  • Evaluating the efficacy of CNT alongside reduced-dose pharmacotherapy presents challenges but shows promise for improved cardiovascular health.

Related Concept Videos